
|Articles|June 26, 2002
Sandhill Scientific Markets New Gastro Diagnostic Tools
Advertisement
HIGHLANDS RANCH, Colo. - Officials from Sandhill Scientific have announced Food and Drug Administration (FDA) approval to market two new modalities for the diagnosis of gastrointestinal disorders.
The MultiChannel Intraluminal Impedance technology was designed to allow characterization of bolus movement within the esophagus. The technology is to be paired with traditional pressure manometry as part of a new device and diagnostic test referred to as esophageal function testing (EFT). It will also be used with a traditional pH ambulatory device that determines reflux episodes.
For additional information, log on to: www.sandhillsci.com.
Advertisement
Advertisement
Advertisement
Trending on Infection Control Today
1
How to Teach Staff to Think Like an Infection Control Preventionist
2
APIC 2026: How Active Surveillance and Genomic Sequencing Helped Control a NICU CLABSI Outbreak
3
From Exposure Event to Action Plan at APIC 2026: Providence Develops Playbook for Managing Large-Scale Patient Notifications
4
Cleaning Beyond Adherence at APIC26: Memorial Hermann Uses Multimodal Education to Strengthen Device Disinfection Practices
5





